Karen Prange is of NEVRO CORP. Currently has a direct ownership of 0 shares of NVRO, which is worth approximately $0. The most recent transaction as insider was on Apr 03, 2025, when has been sold 33,948 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
0% 3M change
100.0% 12M change
Total Value Held $0

Karen Prange Transaction History

Date Transaction Value Shares Traded Shares Held Form
Apr 03 2025
SELL
Sale (or disposition) back to the issuer
-
33,948 Reduced 100.0%
0 Common Stock
May 23 2024
BUY
Grant, award, or other acquisition
-
19,169 Added 36.09%
33,948 Common Stock
May 25 2023
BUY
Grant, award, or other acquisition
-
6,754 Added 31.37%
14,779 Common Stock
May 26 2022
BUY
Grant, award, or other acquisition
-
4,155 Added 34.11%
8,025 Common Stock
May 25 2021
BUY
Grant, award, or other acquisition
-
1,167 Added 23.17%
3,870 Common Stock

Also insider at

ATRC
AtriCure, Inc. Healthcare
VRAY
ViewRay, Inc. Healthcare
EMBC
Embecta Corp. Healthcare
KP

Karen Prange

Mason, OH

Track Institutional and Insider Activities on NVRO

Follow NEVRO CORP and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells NVRO shares.

Notify only if

Insider Trading

Get notified when an Nevro Corp insider buys or sells NVRO shares.

Notify only if

News

Receive news related to NEVRO CORP

Track Activities on NVRO